The Oncology Institute announced the appointment of Jordan McInerney as the new Chief Development Officer, effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A processes for acquisition targets, and establishing MSO platforms to deliver value-based oncology care nationwide. Bringing over 15 years of healthcare leadership, McInerney most recently served as the COO of HOPCo Network Solutions, a subsidiary of Healthcare Outcomes Performance Co.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TOI:
- The Oncology Institute and healthcare company Healthly form alliance
- The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
- Oncology Institute Unveils Clear Financial Outlook for 2024
- Oncology Institute’s Balancing Act: Navigating Goodwill Impairment Amid Financial Strains
- The Oncology Institute, MaxHealth expand value-based care partnership
